benzylpenicilloyl polylysine Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4717 31855-75-1

Description:

MoleculeDescription

Synonyms:

  • benzylpenicilloyl polylysine
  • Molecular weight:
  • Formula: C44H62N8O11S2(C22H30N4O5S)n
  • CLOGP:
  • LIPINSKI: None
  • HAC: 73
  • HDO: 41
  • TPSA:
  • ALOGS:
  • ROTB: 103

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
July 25, 1974 FDA ALLERQUEST

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

Pharmacologic Action:

None

Drug Use (View source of the data)

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
76479814OY UNII
D03095 KEGG_DRUG
4018826 VUID
N0000179051 NUI
4018826 VANDF
C0053327 UMLSCUI
CHEMBL1201779 ChEMBL_ID
DB00895 DRUGBANK_ID
45266800 PUBCHEM_CID
19079 RXNORM
4266 MMSL
d03692 MMSL
003099 NDDF
109202005 SNOMEDCT_US
765118002 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
PRE-PEN HUMAN PRESCRIPTION DRUG LABEL 1 49471-001 INJECTION 60 umol SUBCUTANEOUS NDA 12 sections